1. Home
  2. HALO vs MIDD Comparison

HALO vs MIDD Comparison

Compare HALO & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • MIDD
  • Stock Information
  • Founded
  • HALO 1998
  • MIDD 1888
  • Country
  • HALO United States
  • MIDD United States
  • Employees
  • HALO N/A
  • MIDD N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • MIDD Industrial Machinery/Components
  • Sector
  • HALO Health Care
  • MIDD Industrials
  • Exchange
  • HALO Nasdaq
  • MIDD Nasdaq
  • Market Cap
  • HALO 7.4B
  • MIDD 7.0B
  • IPO Year
  • HALO N/A
  • MIDD N/A
  • Fundamental
  • Price
  • HALO $54.54
  • MIDD $145.79
  • Analyst Decision
  • HALO Buy
  • MIDD Buy
  • Analyst Count
  • HALO 9
  • MIDD 8
  • Target Price
  • HALO $63.56
  • MIDD $171.14
  • AVG Volume (30 Days)
  • HALO 3.3M
  • MIDD 936.9K
  • Earning Date
  • HALO 05-06-2025
  • MIDD 05-07-2025
  • Dividend Yield
  • HALO N/A
  • MIDD N/A
  • EPS Growth
  • HALO 55.40
  • MIDD 11.43
  • EPS
  • HALO 3.76
  • MIDD 8.00
  • Revenue
  • HALO $1,084,306,000.00
  • MIDD $3,854,863,000.00
  • Revenue This Year
  • HALO $25.77
  • MIDD $2.96
  • Revenue Next Year
  • HALO $18.01
  • MIDD $3.58
  • P/E Ratio
  • HALO $14.51
  • MIDD $18.39
  • Revenue Growth
  • HALO 25.64
  • MIDD N/A
  • 52 Week Low
  • HALO $42.01
  • MIDD $118.41
  • 52 Week High
  • HALO $70.51
  • MIDD $182.73
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.48
  • MIDD 53.89
  • Support Level
  • HALO $52.43
  • MIDD $144.36
  • Resistance Level
  • HALO $54.26
  • MIDD $152.22
  • Average True Range (ATR)
  • HALO 3.42
  • MIDD 3.75
  • MACD
  • HALO -0.49
  • MIDD 0.73
  • Stochastic Oscillator
  • HALO 30.60
  • MIDD 69.84

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

Share on Social Networks: